Streetbeat News

Stock Prices

FLS

Flowserve (NYSE:FLS) has seen a 10.71% increase in its short percent of float since the last report, with 1.09 million shares sold short, representing 0.93% of available shares. It would take about 1.46 days to cover these short positions. The increase in short interest can indicate a bearish market sentiment towards Flowserve, although it's lower than its peer group average of 3.20% short interest as a percentage of float. This information suggests investors are showing increased bearishness but Flowserve is still less shorted compared to its peers.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

DKNG

DraftKings (NYSE:DKNG) has seen a 15.59% decrease in short interest, now at 25.37 million shares or 5.74% of float, taking 2.54 days on average to cover. This decline in short interest could indicate a more bullish sentiment towards DKNG compared to its peers, where the average short interest is 3.63% of float.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

VALE

Vale's (NYSE:VALE) short interest has increased by 4.72% since the last report, with 48.12 million shares sold short, representing 1.11% of its float. It would take about 3.03 days to cover all short positions. This rise in short interest indicates a more bearish market sentiment towards Vale, although it has less short interest compared to its peers' average of 4.37%. The increase in short interest doesn't necessarily predict a price drop but suggests traders are betting against the stock.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

APD

Analysts have provided mixed reviews on Air Products & Chemicals (NYSE:APD) with recent ratings ranging from bullish to bearish. The average 12-month price target is now $245.00, a 13.58% decrease from the previous target. The company, a leading industrial gas supplier, reported a revenue decline of -10.61% for the quarter ending September 30, 2023, but maintains strong profitability indicators such as a net margin of 21.7% and an ROE of 4.87%.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

SOLUSD

Solana (CRYPTO: SOL) has experienced a 3.26% decrease in price over the last 24 hours, marking a continuation of its 11.0% decline over the past week. The trading volume for Solana has decreased by 47.0%, while its circulating supply has slightly increased by 0.18%. Currently, Solana's market cap ranks it as the 5th largest, valued at $41.20 billion.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

AHR

American Healthcare REIT, Inc (AHR) is set to IPO on February 7th on the NYSE, with shares priced between $12.00 and $15.00. The company, which operates a diversified portfolio of healthcare real estate, has a 180-day insider lock-up period ending on August 5, 2024.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 3:00 pm

WWW

Traders are circulating rumors that Wolverine World Wide (WWW) has attracted the attention of an activist investor, potentially indicating upcoming changes or actions aimed at enhancing shareholder value.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:57 pm

VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced positive results from its Phase 3 trials of the vanzacaftor/tezacaftor/deutivacaftor (vanza triple) treatment for cystic fibrosis, showing non-inferiority to Trikafta and superiority in reducing sweat chloride levels. The company also reported Q4 2023 adjusted EPS of $4.20, beating consensus, with sales of $2.52 billion. Vertex expects FY 2024 sales of $10.55 billion-$10.75 billion and plans to submit new drug applications by mid-2024.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 2:57 pm

AGFY

BRTX

LLY

NVIV

PRSO

SUNW

TENX

U.S. stocks traded higher with the Dow Jones gaining over 100 points. Eli Lilly reported better-than-expected Q4 earnings, with a 28% Y/Y revenue increase to $9.35 billion and an adjusted EPS of $2.49. InVivo Therapeutics, Tenax Therapeutics, and Agrify Corporation saw significant stock price increases, while Sunworks, BioRestorative Therapies, and Peraso Inc. experienced notable declines. Oil and gold saw minor price movements.

Portfolio Pulse from Avi Kapoor

February 06, 2024 | 2:52 pm

UBS

UBS Group AG reported a Q4 2023 net loss of $279 million, an improvement from Q3's $715 million loss but down from the previous year's $1.6 billion profit. Sales rose 35% Y/Y to $10.9 billion, beating consensus. The consolidation with Credit Suisse contributed to Global Wealth Management's revenue increase and net new assets. UBS plans a $0.70 per share dividend for 2023 and expects to buy back up to $1 billion in shares in 2024. Shares fell 4.73% to $28.38.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 2:48 pm